1-chloro-5-trifluoromethyl-isoquinoline | 435278-04-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 1-chloro-5-trifluoromethyl-isoquinoline
• 英文别名: 1-Chloro-5-(trifluoromethyl)isoquinoline
• CAS: 435278-04-9
• 化学式: C₁₀H₅ClF₃N
• 分子量: 231.605
• InChiKey: VTLLEQMXSWJONO-UHFFFAOYSA-N

物化性质

• 沸点：
  296.3±35.0 °C(Predicted)
• 密度：
  1.427

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• [EN] HEPATITIS C VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS DE L'HEPATITE C
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2003099274A1

  公开（公告）日：2003-12-04

  Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.

  丙型肝炎病毒抑制剂公开了具有以下通式：其中R1、R2、R3、R'、B、Y和X在描述中有所描述。还公开了包含该化合物的组合物以及使用该化合物抑制HCV的方法。
• Hepatitis C virus inhibitors
  申请人：Scola Michael Paul

  公开号：US20050267040A1

  公开（公告）日：2005-12-01

  Hepatitis C virus inhibitors are having the general formula: wherein A, R 2 , R 3 , R′, B and Y are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

  丙型肝炎病毒抑制剂的一般式为：其中A、R2、R3、R'、B和Y在说明书中有描述。还公开了包含该化合物的组合物和使用该化合物抑制HCV的方法。
• Luminescence device and display apparatus
  申请人：Canon Kabushiki Kaisha

  公开号：US20030068526A1

  公开（公告）日：2003-04-10

  A luminescence device having a layer containing a metal coordination compound which has a partial structure ML m of formula (2) below and is preferably entirely represented by formula (3) below: ML m L′ n (3), wherein M denotes a metal atom of Ir, Pt, Rh or Pd; represent mutually different bidentate ligands; m is 1 or 2 or 3; n is 0 or 1 or 2 with the proviso that m+n=2 or 3; the partial structure ML m is represented by formula (2) below (wherein B is an isoquinolyl group bonded to the metal M with its N and including a position-1 carbon atom bonded to a cyclic group A which includes the C bonded to the metal M), and the partial structure ML′ n is represented by formula (4), (5) or (6) shown below. There is provided a luminescence device capable of high-efficiency luminescence and long-term high luminance and adapted to red luminescence. 1

  一种发光装置，其包含一个层，其中包含具有部分结构为MLm的金属配位化合物，该配位化合物最好完全由以下公式（3）表示：MLmL'n（3），其中M表示Ir，Pt，Rh或Pd的金属原子；表示互不相同的双齿配体；m为1或2或3；n为0或1或2，但m+n=2或3；部分结构MLm由以下公式（2）表示（其中B是与金属M结合并包括与环状基团A结合的位置1碳原子的异喹啉基团），部分结构ML'n由以下公式（4） ，（5）或（6）表示。提供了一种适用于红色发光的高效发光和长期高亮度的发光装置。
• LUMINESCENCE DEVICE AND DISPLAY APPARATUS
  申请人：Kamatani Jun

  公开号：US20070212570A1

  公开（公告）日：2007-09-13

  A metal coordination compound having the following structure: wherein M′ is Ir or Rh, m′ is 2, and are identical to each other and are represented by a substituted or unsubstituted phenyl isoquinoline ligand. A luminescence device and a display apparatus using this metal coordination is compound are provided.

  一种具有以下结构的金属配位化合物：其中M'为Ir或Rh，m'为2，R1，R2和R3相同且由替代或未替代的苯基异喹啉配体表示。提供了使用此金属配位化合物的发光装置和显示装置。
• HEPATITIS C VIRUS INHIBITORS
  申请人：Wang Alan Xiangdong

  公开号：US20090274656A1

  公开（公告）日：2009-11-05

  Hepatitis C virus inhibitors are disclosed having the general formula: wherein R 1 , R 2 , R 3 , R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

  本发明揭示了一种具有一般式的丙型肝炎病毒抑制剂：其中R1、R2、R3、R'、B、Y和X在说明书中有所描述。还揭示了包含该化合物的组合物以及使用该化合物抑制HCV的方法。